Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS

Postby ton » Tue Jun 07, 2016 9:20 am

:sad: Biogen Reports Top-Line Results from Phase 2 Study of Opicinumab (Anti-LINGO-1) in Multiple Sclerosis

http://media.biogen.com/press-release/i ... anti-lingo
User avatar
ton
Family Member
 
Posts: 71
Joined: Thu May 27, 2010 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service